Suppr超能文献

孤啡肽(N/OFQ)肽(NOP)受体调节的细胞机制和 N/OFQ 的异源调节。

Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.

机构信息

Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.

出版信息

Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb 8.

Abstract

The nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor is the fourth and most recently discovered member of the opioid receptor superfamily that also includes μ, δ, and κ opioid receptor subtypes (MOR, DOR, and KOR, respectively). The widespread anatomic distribution of the NOP receptor enables the modulation of several physiologic processes by its endogenous agonist, N/OFQ. Accordingly, the NOP receptor has gained a lot of attention as a potential target for the development of ligands with therapeutic use in several pathophysiological states. NOP receptor activation frequently results in effects opposing classic opioid receptor action; therefore, regulation of the NOP receptor and conditions affecting its modulatory tone are important to understand. Mounting evidence reveals a heterologous interaction of the NOP receptor with other G protein-coupled receptors, including MOR, DOR, and KOR, which may subsequently influence their function. Our focus in this review is to summarize and discuss the findings that delineate the cellular mechanisms of NOP receptor signaling and regulation and the regulation of other receptors by N/OFQ and the NOP receptor.

摘要

孤啡肽(N/OFQ)肽(NOP)受体是阿片受体超家族的第四个也是最新发现的成员,该超家族还包括 μ、δ 和 κ 阿片受体亚型(分别为 MOR、DOR 和 KOR)。NOP 受体的广泛解剖分布使其内源性激动剂 N/OFQ 能够调节多种生理过程。因此,NOP 受体作为治疗几种病理生理状态的配体的潜在靶点引起了广泛关注。NOP 受体的激活通常会导致与经典阿片受体作用相反的效果;因此,调节 NOP 受体及其调节音调的条件对于理解非常重要。越来越多的证据表明 NOP 受体与其他 G 蛋白偶联受体(包括 MOR、DOR 和 KOR)的异源相互作用,这可能随后影响它们的功能。我们在这篇综述中的重点是总结和讨论阐明 NOP 受体信号转导和调节以及 N/OFQ 和 NOP 受体对其他受体调节的细胞机制的发现。

相似文献

1
2
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Pharmacol Ther. 2014 Mar;141(3):283-99. doi: 10.1016/j.pharmthera.2013.10.011. Epub 2013 Nov 1.
3
Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development.
Chem Biodivers. 2021 Jan;18(1):e2000871. doi: 10.1002/cbdv.202000871. Epub 2020 Dec 22.
5
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.
Pharmacol Rev. 2016 Apr;68(2):419-57. doi: 10.1124/pr.114.009209. Epub 2016 Mar 8.
8
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
Nature. 2012 May 16;485(7398):395-9. doi: 10.1038/nature11085.
9
Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases.
Vitam Horm. 2015;97:241-66. doi: 10.1016/bs.vh.2014.11.003. Epub 2015 Jan 14.
10
Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
Curr Drug Targets. 2007 Jan;8(1):117-35. doi: 10.2174/138945007779315605.

引用本文的文献

1
B cell-derived nociceptin/orphanin FQ contributes to impaired glucose tolerance and insulin resistance in obesity.
iScience. 2025 Jun 4;28(7):112819. doi: 10.1016/j.isci.2025.112819. eCollection 2025 Jul 18.
3
Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.
Nat Commun. 2024 Jun 25;15(1):5353. doi: 10.1038/s41467-024-49712-0.
4
Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA receptor-mediated mechanism.
Neuropharmacology. 2024 May 1;248:109866. doi: 10.1016/j.neuropharm.2024.109866. Epub 2024 Feb 15.
5
Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release.
bioRxiv. 2024 May 22:2023.05.26.542102. doi: 10.1101/2023.05.26.542102.
6
Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics.
Neuropharmacology. 2023 Mar 15;226:109408. doi: 10.1016/j.neuropharm.2022.109408. Epub 2022 Dec 28.
9
Endogenous opioid systems alterations in pain and opioid use disorder.
Front Syst Neurosci. 2022 Oct 19;16:1014768. doi: 10.3389/fnsys.2022.1014768. eCollection 2022.
10
The opioid system in depression.
Neurosci Biobehav Rev. 2022 Sep;140:104800. doi: 10.1016/j.neubiorev.2022.104800. Epub 2022 Jul 30.

本文引用的文献

1
Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling.
J Biol Chem. 2012 Dec 7;287(50):42019-30. doi: 10.1074/jbc.M112.405696. Epub 2012 Oct 19.
2
Sex differences in the Nociceptin/Orphanin FQ system in rat spinal cord following chronic morphine treatment.
Neuropharmacology. 2012 Sep;63(3):427-33. doi: 10.1016/j.neuropharm.2012.04.028. Epub 2012 May 2.
3
Inheritance and memory of stress-induced epigenome change: roles played by the ATF-2 family of transcription factors.
Genes Cells. 2012 Apr;17(4):249-63. doi: 10.1111/j.1365-2443.2012.01587.x. Epub 2012 Mar 1.
5
Chemokines and cytokines in neuroinflammation leading to neuropathic pain.
Curr Opin Pharmacol. 2012 Feb;12(1):55-61. doi: 10.1016/j.coph.2011.10.007. Epub 2011 Oct 21.
6
Nociceptin/orphanin FQ receptor-driven heterologous desensitization of the major HIV-1 co-receptor CXCR4.
J Neuroimmune Pharmacol. 2011 Dec;6(4):546-50. doi: 10.1007/s11481-011-9285-4. Epub 2011 Jun 9.
7
∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells.
J Mol Neurosci. 2012 Feb;46(2):285-92. doi: 10.1007/s12031-011-9552-0. Epub 2011 May 21.
8
Orphanin FQ/nociceptin activates nuclear factor kappa B.
J Neuroimmune Pharmacol. 2011 Dec;6(4):617-25. doi: 10.1007/s11481-011-9279-2. Epub 2011 May 6.
9
The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction.
Neuropeptides. 2011 Aug;45(4):247-61. doi: 10.1016/j.npep.2011.03.002. Epub 2011 Apr 8.
10
Interactions between the immune and nervous systems in pain.
Nat Med. 2010 Nov;16(11):1267-76. doi: 10.1038/nm.2234. Epub 2010 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验